Maheedhar Gedela, MD
Interventional Cardiology · Wichita, KSNPI 1104231216
Payments from drug & device makers
Across 600 payments — averaging $90.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$29K
- Abbott$9K
- Edwards Lifesciences$4K
- Abiomed$2K
- Philips North America LLC$2K
- Boston Scientific$1K
- plus $8K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 105 | $29,087 |
| Abbott | 128 | $8,595 |
| Edwards Lifesciences | 28 | $3,505 |
| Abiomed | 19 | $1,996 |
| Philips North America LLC | 15 | $1,850 |
| Boston Scientific | 26 | $1,181 |
| Cardiovascular Systems Inc. | 34 | $1,082 |
| Shockwave Medical, Inc | 27 | $948 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 40 | $680 |
| Amgen | 26 | $672 |
| AstraZeneca | 17 | $553 |
| Chiesi USA, Inc. | 23 | $551 |
| Siemens Medical Solutions USA, Inc. | 2 | $522 |
| E.r. Squibb & Sons, L.L.C. | 26 | $432 |
| Terumo Medical Corporation | 17 | $424 |
| Pfizer | 17 | $408 |
| Biotronik Inc. | 10 | $351 |
| Johnson & Johnson | 7 | $260 |
| Astellas Pharma US Inc | 2 | $190 |
| Acist Medical Systems, Inc. | 2 | $165 |
| Cordis US CORP. | 4 | $133 |
| Biosense Webster, Inc. | 1 | $120 |
| Novartis | 6 | $98 |
| Cardiva Medical, Inc. | 3 | $91 |
| Teleflex LLC | 4 | $90 |
| Heartflow, Inc. | 1 | $57 |
| Asahi Intecc USA, Inc. | 2 | $50 |
| Penumbra, Inc. | 1 | $49 |
| Getinge USA Sales, LLC | 1 | $38 |
| Cardinal Health 200 LLC | 1 | $28 |
| Actelion Pharmaceuticals US, Inc. | 1 | $27 |
| W. L. Gore & Associates, Inc. | 1 | $24 |
| Vifor Pharma, Inc. | 1 | $17 |
| Cardiofocus, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
How this compares
$54,301 in reported general payments places this provider in the 85th percentile of 55 interventional cardiology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Wichita
- Hussam FarhoudWichita$270K
- Christian HouraniWichita$17K
- Gaurav TyagiWichita$13K
- Ravi BajajWichita$10K
- Assem FarhatWichita$9K
- Venkata BoppanaWichita$9K
- Alaa BouladWichita$8K
- Rohma ShaikhWichita$4K
- George ReaderWichita$4K
- Mohamed ElmassryWichita$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.